https://doi.org/10.1016/s2468-1253(20)30290-9
L
Lauranne Piron
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
1.8K
Citations
16
h-index
20
i10-index
Lauranne Piron is an academic researcher from Centre Hospitalier Universitaire de Montpellier. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation. The author has an h-index of 16, co-authored 23 publications.
ORCID: 0000-0003-2916-3770Papers by this author
worksPersonalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
2020 · The Lancet. Gastroenterology & hepatology · 568 citations
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
2020 · The Lancet. Gastroenterology & hepatology · 568 citations
https://doi.org/10.1016/s2468-1253(20)30290-9
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
2020 · BMC Cancer · 50 citations
https://doi.org/10.1186/s12885-020-07065-z
Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center
2022 · Critical Care · 10 citations
https://doi.org/10.1186/s13054-022-04165-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat